Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
DSP-0390 by Sumitomo Pharma for Anaplastic Astrocytoma: Likelihood of Approval
DSP-0390 is under clinical development by Sumitomo Pharma and currently in Phase II for Anaplastic Astrocytoma. According to GlobalData, Phase...
Data Insights
DSP-0390 by Sumitomo Pharma for Oligodendroglioma: Likelihood of Approval
DSP-0390 is under clinical development by Sumitomo Pharma and currently in Phase II for Oligodendroglioma. According to GlobalData, Phase II...